Methaemoglobinaemia after inhalation of nitric oxide for treatment of hydrochlorothiazide-induced pulmonary oedema.
Hovenga
S
S
Koenders
M E
ME
van der Werf
T S
TS
Moshage
H
H
Zijlstra
J G
JG
D000280:Administration, Inhalation; D000931:Antidotes / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D008706:Methemoglobin / Q000032:analysis; D008708:Methemoglobinemia / Q000139:chemically induced*; D008751:Methylene Blue / Q000627:therapeutic use; D008875:Middle Aged; D009566:Nitrates / Q000097:blood / Q000652:urine; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects*; D010101:Oxygen Consumption; D011654:Pulmonary Edema / Q000139:chemically induced / Q000188:drug therapy*; D012121:Respiration, Artificial
D000931:Antidotes; D000959:Antihypertensive Agents; D006454:Hemoglobins; D009566:Nitrates; D006852:Hydrochlorothiazide; D009569:Nitric Oxide; D008706:Methemoglobin; D008751:Methylene Blue